Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

7: Mesenchymal stem cellsECCO'16 Amsterdam
Year: 2016
Authors: Vetrano S., Egan L.
Stem cell transplantion / therapy, Crohn's Disease
Files: 1
7: Proximity Extension Assay technology identifies novel serum biomarkers EU Project Forum
Year: 2016
Authors: Nordberg N.
BIOMARKERS
Files: 1
7: Smoking3rd EpiCom Workshop
Year: 2016
Authors: Lakatos P.
Crohn's Disease, Ulcerative Colitis, environment, smoking
Files: 1
7: Ulcerative Colitis vs. Crohn’s Disease in difficult cases1st H-ECCO IBD Masterclass
Year: 2016
Authors: Villanacci V.
Crohn's Disease, Ulcerative Colitis, histology
Files: 1
7: What do patients think?3rd Basic ECCO: EduCational COurse for Industry
Year: 2016
Authors: Harbord M.
ANAEMIA, PSYCHOL COMORB, FATIGUE, PATIENT CHOICE
Files: 1
7a: Managing IBD and pregnancy 14th IBD Intensive Advanced Course
Year: 2016
Authors: Van der Woude J., Zelinkova Z.
Fertility, IBD and breastfeeding, IBD in pregnancy
Files: 1
7b: Managing complications associated with anti-TNF therapy14th IBD Intensive Advanced Course
Year: 2016
Authors: Ben-Horin S.
CMV, Concomitant infections, EBV, Hepatosplenic T cell lymphoma, IBD in the elderly, Immunisation, Vaccination, Lymphoma, Tuberculosis
Files: 1
7c: Managing extraintestinal manifestations of IBD14th IBD Intensive Advanced Course
Year: 2016
Authors: Vavricka S., Lakatos P.
Other extraintestinal manifestations
Files: 1
8: A novel diagnostic test for determining microbial dysbiosis EU Project Forum
Year: 2016
Authors: Casén C.
MICROBIOTA
Files: 1
8: Abstract 5+6: Host-microbiome interactions in primary sclerosing cholangitis & genetic risk for Crohn’s Disease has little impact on intestinal microbiota composition2nd Y-ECCO Basic Science Workshop
Year: 2016
Authors: Sabino J.
genetic, microbiota
Files: 1
8: Best abstract: Predicting short and medium-term efficacy of the biosimilar infliximab: Trough levels/ADAs or clinical/biochemical markers play a more important role?ECCO'16 Amsterdam
Year: 2016
Authors: Golovics P.
biosimilars, anti-TNF drug levels, therapeutic drug monitoring
Files: 1
8: Comparing treatment strategies and cost effectiveness 5th ClinCom Workshop
Year: 2016
Authors: Hommes D.
health economic analysis
Files: 1
8: Dietary treatment of functional symptoms in IBD1st D-ECCO Workshop
Year: 2016
Authors: Lomer M.
IBD, non inflammatory symptoms, visceral pain FODMAP
Files: 1
8: Experience from Sweden: Swibreg10th N-ECCO Network Meeting
Year: 2016
Authors: Jäghult S.
Files: 1
8: How is care organised?3rd Basic ECCO: EduCational COurse for Industry
Year: 2016
Authors: Hart A.
IBD, Crohn's Disease, Ulcerative Colitis
Files: 1
8: Paediatric and adolescent IBD1st H-ECCO IBD Masterclass
Year: 2016
Authors: Borralho P.
Ulcerative Colitis, Crohn's Disease, histology, paediatrics
Files: 1
8: Presentation and discussion of the case on migration3rd EpiCom Workshop
Year: 2016
Authors: Yassin N.
Epidemiology
Files: 1
8: Reconstructive repair5th S-ECCO IBD Masterclass
Year: 2016
Authors: Panis Y.
rectovaginal fistula, Crohn's Disease
Files: 1
8a: Role of bowel ultrasonography in intestinal diseases14th IBD Intensive Advanced Course
Year: 2016
Authors: Vavricka S., Kucharzik T.
ULTRASOUND
Files: 1
8a: Workshop 2 – CD Management (Group B)7th N-ECCO School
Year: 2016
Authors: De Boer N.
ANTI-TNF AGENTS, THIOPURINES, THERAPUTIC DRUG MONITORING
Files: 1